Cargando…
Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996328/ https://www.ncbi.nlm.nih.gov/pubmed/33668396 http://dx.doi.org/10.3390/ph14030179 |
_version_ | 1783670092417990656 |
---|---|
author | Ostrowska, Kinga Leśniak, Anna Czarnocka, Zuzanna Chmiel, Jagoda Bujalska-Zadrożny, Magdalena Trzaskowski, Bartosz |
author_facet | Ostrowska, Kinga Leśniak, Anna Czarnocka, Zuzanna Chmiel, Jagoda Bujalska-Zadrożny, Magdalena Trzaskowski, Bartosz |
author_sort | Ostrowska, Kinga |
collection | PubMed |
description | We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and 5-HT(2A)R Ki for one ligand as well as numerous low nanomolar estimates of K(i) for both receptors. Intrigued by these results we synthesized all 60 new derivatives using microwave-assisted protocols. We show that three new compounds show a relatively high antagonistic activity against the 5HT(1A) receptor, although lower than the reference compound WAY-100635. These compounds also showed relatively low binding affinities to the 5-HT(2A) receptor. We also provide a detailed structure–activity analysis of this series of compounds and compare it with previously obtained results for an exhaustive series of coumarin derivatives. |
format | Online Article Text |
id | pubmed-7996328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79963282021-03-27 Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists Ostrowska, Kinga Leśniak, Anna Czarnocka, Zuzanna Chmiel, Jagoda Bujalska-Zadrożny, Magdalena Trzaskowski, Bartosz Pharmaceuticals (Basel) Article We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and 5-HT(2A)R Ki for one ligand as well as numerous low nanomolar estimates of K(i) for both receptors. Intrigued by these results we synthesized all 60 new derivatives using microwave-assisted protocols. We show that three new compounds show a relatively high antagonistic activity against the 5HT(1A) receptor, although lower than the reference compound WAY-100635. These compounds also showed relatively low binding affinities to the 5-HT(2A) receptor. We also provide a detailed structure–activity analysis of this series of compounds and compare it with previously obtained results for an exhaustive series of coumarin derivatives. MDPI 2021-02-24 /pmc/articles/PMC7996328/ /pubmed/33668396 http://dx.doi.org/10.3390/ph14030179 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Ostrowska, Kinga Leśniak, Anna Czarnocka, Zuzanna Chmiel, Jagoda Bujalska-Zadrożny, Magdalena Trzaskowski, Bartosz Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title | Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title_full | Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title_fullStr | Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title_full_unstemmed | Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title_short | Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists |
title_sort | design, synthesis, and biological evaluation of a series of 5- and 7-hydroxycoumarin derivatives as 5-ht(1a) serotonin receptor antagonists |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996328/ https://www.ncbi.nlm.nih.gov/pubmed/33668396 http://dx.doi.org/10.3390/ph14030179 |
work_keys_str_mv | AT ostrowskakinga designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists AT lesniakanna designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists AT czarnockazuzanna designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists AT chmieljagoda designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists AT bujalskazadroznymagdalena designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists AT trzaskowskibartosz designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists |